MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • MDS Virtual Congress 2020

    Preoperative higher impulsivity leads to better quality of life after deep brain stimulation in Parkinson’s disease

    T. Yamamoto, W. Liu, Y. Yamanaka, M. Asahina, T. Uchiyama, S. Hirano, K. Shimizu, Y. Higuchi, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to explore which cognitive functions and neuropsychiatric symptoms affect QOL, and are therefore predictive of changes in QOL, before and after DBS…
  • MDS Virtual Congress 2020

    Novel GNO1 mutation in monozygotic twins responsive to DBS

    B. Bulica (West Bloomfield, MI, USA)

    Objective: GNAO1 is located on chromosome 16q12.2 and encodes Gα0 subunit of the heterotrimeric guanine-binding protein necessary for neuronal signaling. It is thought that loss-of-function GNAO1…
  • MDS Virtual Congress 2020

    Bilateral double beta peaks in a PD patient with STN electrodes

    T. Koeglsperger, J. Mehrkens, K. Bötzel (Munich, Germany)

    Objective: We aimed to record LFPs of the subthalamic nucleus (STN) from a PD patient with a new implantable pulse generator (IPG), which is capable…
  • MDS Virtual Congress 2020

    Real-World Data on the Use of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease who are Treated with Deep Brain Stimulation: The PD-DUAL Study

    J. Aldred, F. Amjad, A. Johnson, P. Kukreja, I. Malaty, S. Parashos, J. Siddiqui, M. Siddiqui, J. Zamudio, S. Thakkar (Spokane, WA, USA)

    Objective: To examine the use of oral anti-parkinsonian medications in advanced Parkinson’s disease (APD) patients who have a history of, or current treatment with deep…
  • MDS Virtual Congress 2020

    Cerebrotendinous Xanthomatosis Tremor Successfully Controlled post-VIM-Deep Brain Stimulation

    S. De Jesus, J. Davanzo, J. McInerney, E. Farace (Hershey, PA, USA)

    Objective: Report on tolerability of VIM-deep brain stimulation (DBS) in a patient with cerebrotendinous xanthomatosis (CTX) and medication refractory unilateral tremor. Background: CTX is a…
  • MDS Virtual Congress 2020

    Preference and Satisfaction of the Deep Brain Stimulation Battery in the Patients with Hypokinetic Movement Disorders

    X. Qiu, CC. Zhang, Z.Y Lin, Y.H Wang, Y.W Wu, D.Y Li (Shanghai, China)

    Objective: To evaluate the preference and satisfaction of the deep brain stimulation implantable pulse generator in patients with hypokinetic movement disorders. Background: Deep brain stimulation (DBS)…
  • MDS Virtual Congress 2020

    “Motor” DDS: is motor sensitization underestimated after STN-DBS?

    M. Ciocca, A. Bocum, Y. Tai (London, United Kingdom)

    Objective: Dopamine dysregulation syndrome (DDS) is a phenomenon where Parkinson’s disease (PD) patients develop an addictive pattern of dopaminergic drug intake, mainly to avoid the…
  • MDS Virtual Congress 2020

    Evaluation of the effect of Bilateral Subthalamic Nucleus Deep Brain Stimulation on fatigue in Parkinson’s disease

    C. Lazcano Ocampo, K. Ashkan, D. van Wamelen, M. Samuel, M. Silverdale, A. Rizos, H. Dafsari, A. Sauerbier, J. Koch, A. Podlewska, V. Leta, L. Timmermann, K. Chaudhuri (London, United Kingdom)

    Objective: To determine the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on fatigue in PD patients. Background: Fatigue is a common and disabling…
  • MDS Virtual Congress 2020

    Twiddler’s Syndrome in Deep Brain Stimulation

    V. Shivkumar, J. Adams (Huntington, WV, USA)

    Objective: We describe a case of Twiddler’s syndrome in a patient who underwent DBS surgery. Background: Twiddler’s syndrome was first described in 1968 in cardiac…
  • MDS Virtual Congress 2020

    Clinical Effect of Impedance Variations within Normal Limits in Parkinson’s Disease Treated with Subthalamic Deep Brain Stimulation

    A.Y Yilmaz, A. Savas, C. Akbostanci (Ankara, Turkey)

    Objective: We aim to test whether lower impedance values (within normal limits) are associated with better clinical outcome in Parkinson’s disease (PD) patients treated with subthalamic…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 152
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #24475 (not found)
  • #23043 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • #24752 (not found)
  • Erotophonophilia and severe impulse control disorder in a patient with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley